IVIG

IVIG is a special type of medicine made from human blood. It helps your body fight off infections and other problems. Doctors give it to people who don't make enough of their own antibodies, like those with certain immune system disorders or after some infections.

Brand names:Gammagard, Gamunex, Privigen
Medication

What people taking IVIG report

Every report comes from a Lived member, sent anonymously.

Have you tried IVIG for Common Variable Immunodeficiency?

NameHow it went

About IVIG

What It's For

IVIG (intravenous immunoglobulin) is a concentrate of antibodies, the infection-fighting proteins of the immune system, collected from the donated plasma of thousands of healthy people and given through a vein. Familiar brands include Privigen, Gammagard and Gamunex-C. It is used in two quite different ways. The first is replacement. People with primary immunodeficiency, a group of inherited conditions such as common variable immunodeficiency (CVID) and X-linked agammaglobulinemia, cannot make enough working antibodies, and regular IVIG supplies what their body lacks. Some products are also approved to prevent bacterial infections in people with chronic lymphocytic leukemia (CLL, a blood cancer) whose antibody levels are low or who keep getting infections. The second is calming an immune system that is attacking the body. Here IVIG is given in much higher doses. Approved uses include chronic immune thrombocytopenia (ITP), in which antibodies destroy platelets and raise the risk of bleeding; chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy, in which the immune system damages nerves and causes weakness; and Kawasaki disease in children, where it helps prevent damage to the heart's arteries. Doctors also use it for Guillain-Barré syndrome, a sudden immune attack on the nerves, where research shows that IVIG started within two weeks speeds recovery about as much as plasma exchange (filtering antibodies out of the blood). Each brand has its own list of approved conditions, so the product chosen depends partly on what it is being used for.

How It Works

IVIG is mostly IgG, the main type of antibody in the blood. Because it is pooled from many donors, it carries antibodies against a very wide range of bacteria and viruses. For someone who cannot make their own, these borrowed antibodies tag germs for destruction and neutralize them, much as their own antibodies would. The protection is temporary: the body gradually breaks the antibodies down, which is why infusions are repeated every few weeks. In autoimmune and inflammatory conditions, the effect is different and less fully understood. High doses of donor antibodies appear to dampen the immune system's misdirected attack, although researchers have not fully worked out how. In ITP, the practical result is that platelets are destroyed less quickly, so the count rises.

Dosage & Administration

IVIG is given as an infusion into a vein by a nurse or other healthcare provider, in a hospital, infusion center, doctor's office or at home with nursing support. The dose is based on body weight and the condition being treated. For immunodeficiency, infusions are usually given every three to four weeks, and the dose is adjusted over time using blood tests of antibody levels and how often infections occur. For conditions such as ITP and CIDP, a larger dose is usually spread over two to five days, and some people with CIDP then continue with regular maintenance infusions. The infusion starts slowly and is sped up only if it is well tolerated, so a session typically lasts two to six hours. Drinking enough fluid beforehand matters, because good hydration lowers the risk of kidney problems and post-infusion headache. People who react to infusions are sometimes given medicines such as acetaminophen or an antihistamine beforehand.

Side Effects

Headache, tiredness, chills, fever, nausea, muscle or back aches and flushing are the most common side effects. They usually happen during the infusion or within a day or so, and many are linked to the infusion running too fast, so slowing it often helps. Some people feel washed out for a day or two afterward. A severe allergic reaction is rare. Hives, chest tightness, wheezing or feeling faint during an infusion should be reported to the nurse at once so the infusion can be stopped and treated. In the days after an infusion, contact the care team right away about a severe headache with a stiff neck, fever or sensitivity to light, which can signal a non-infectious inflammation of the lining of the brain (aseptic meningitis); passing much less urine or sudden weight gain or swelling, which can signal kidney strain; dark urine or yellowing of the skin or eyes, which can mean red blood cells are breaking down; or pain, warmth and swelling in an arm or leg. Sudden chest pain, sudden shortness of breath, or numbness or weakness on one side of the body can signal a dangerous blood clot and need emergency care by calling 911.

Interactions & Warnings

IVIG carries a boxed warning from the US Food and Drug Administration (FDA), the agency's most prominent warning, for blood clots and for kidney damage, including sudden kidney failure. Clots are more likely in older people and in those who are immobile, have had clots before, have a clotting disorder, use estrogen, have a central venous line or have heart and blood vessel risk factors, although clots can happen without any of these. Kidney problems are more likely in people over 65 and in those with existing kidney disease, diabetes, dehydration or a serious infection, or who take other medicines that can harm the kidneys. For people at higher risk, the care team checks kidney function, uses the lowest practical dose and infusion speed, and makes sure they are well hydrated. Some people have very low levels of IgA, a different type of antibody, and have developed antibodies against it. They are at higher risk of a severe allergic reaction, because IVIG contains small amounts of IgA. Anyone who has had a severe reaction to an immune globulin product before should generally not receive it again. IVIG can stop live vaccines, such as the measles, mumps and rubella (MMR) and chickenpox vaccines, from working properly, so whoever gives a vaccine should know about recent IVIG. The donor antibodies can also make some antibody-based blood tests harder to interpret. Because IVIG is made from human plasma, there is a small theoretical risk of passing on an infection; donor screening and virus-removal steps during manufacturing make this unlikely. In pregnancy it is given only when clearly needed, since little human data exists.

What to Expect

For immunodeficiency, IVIG is usually a long-term, often lifelong, routine. It does not prevent every infection, especially before the right dose is found, but infections should become noticeably less frequent and less severe. Regular checks of antibody levels, particularly the trough level just before the next infusion, help guide the dose. Some people switch to subcutaneous immunoglobulin, which is infused under the skin at home, more often and in smaller amounts, and tends to cause fewer whole-body side effects. In ITP, IVIG is used to raise the platelet count to control or prevent bleeding, or to make surgery safer. In CIDP, the aim is better strength and less disability. After a good initial response, not everyone needs indefinite maintenance, and the care team may try spacing out or lowering doses to find the least treatment that keeps symptoms under control. Some insurers cover IVIG only in certain settings, such as an infusion center or at home, so it is worth checking coverage before the first infusion.

Questions to Ask Your Doctor

  1. 1.Why is IVIG recommended for my condition, and what are the alternatives, such as subcutaneous immunoglobulin or other treatments?
  2. 2.How will we know whether IVIG is working, and how soon should I expect a change?
  3. 3.Do I have any risk factors for blood clots or kidney problems, and what will we do to lower them?
  4. 4.What can we do if I get headaches or other side effects after infusions?
  5. 5.How long am I likely to need IVIG, and is there a plan to reassess the dose or stop?

Last reviewed • Oct 2026

Educational content, not medical advice.